Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
about
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
description
scientific article published on 19 November 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@en
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@nl
type
label
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@en
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@nl
prefLabel
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@en
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@nl
P2093
P356
P1476
Direct-acting antivirals-based ...... tein 4 in hepatitis C patients
@en
P2093
Anders Schlosser
Barbara Sitek
Christian Mölleken
Christoph Sarrazin
Grith Lykke Sorensen
Helmut E Meyer
Julia Dietz
Maike Ahrens
Martin Eisenacher
Uffe Holmskov
P356
10.3350/CMH.2018.0029
P407
P50
P577
2018-11-19T00:00:00Z